advertisement

Colds and flu

08 June 2010

Experts find compound to fight bird, seasonal flu

Scientists have identified a chemical compound that can stop the H5N1 bird flu virus as well as seasonal human flu viruses from replicating.Finding new flu drugs is essential as flu viruses mutate and are adept at evading the limited array of antiviral drugs

0

This article has not necessarily been edited by Health24.

HONG KONG, May 31 (Reuters) - Scientists have identified a chemical compound that can stop the H5N1 bird flu virus as well as seasonal human flu viruses from replicating.Finding new flu drugs is essential as flu viruses mutate and are adept at evading the limited array of antiviral drugs.In a paper published in Nature Biotechnology, scientists from Hong Kong and Canada said they had found a chemical "nucleozin", which fought off both seasonal flu viruses and the H5N1 in mice as well as in cell culture."We have now brand-new weapons to combat influenza virus resistant to ... (antiviral drugs like) oseltamivir and zanamivir," said microbiologist Richard Yao at the University of Hong Kong, who led the study.Nearly all of the seasonal H1N1 viruses circulating in the United States in the 2008-2009 flu season were resistant to Roche AG and Gilead Sciences Inc's Tamiflu, known generically as oseltamivir, according to the paper.Adamantanes, an older class of drugs, was also powerless against seasonal H3N2 flu viruses in the United States during that same period.Zanamivir is the generic name for Relenza, GlaxoSmithKline and Biota Inc's flu drug.Nucleozin targetted a protein in flu viruses, called nucleoprotein, that was responsible for virus replication, Yao said in reply to questions from Reuters.Yao said they selected nucleozin from a chemical library with more than 50,000 compounds, the same library which experts here used to study the SARS virus."Nucleozin is highly potent in cell culture and also in mice infected with the highly pathogenic influenza virus H5N1 ... (it can) stop the virus from replicating," Yao said.The compound was effective against H1N1, H3N2, and H5N1 viruses and researchers can now target nucleoprotein to fight flu, Yao said."Scientists could now use nucleoprotein as a target to develop antiviral therapeutics for the treament of influenza infection," he said.A cousin of the new H1N1 swine flu virus, the seasonal H1N1, has been circulating widely for a long time. SARS surfaced in southern China in 2003, killing about 800 people world-wide.The H5N1, although mainly a disease in birds, has a mortality rate of 60 percent on the rare occasions when it infects people. It was first discovered in people in 1997.

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.

Ask the Expert

Flu expert

Dr Heidi van Deventer completed her MBChB (Bachelor of Medicine and Bachelor of Surgery) degree in 2004 at the University of Stellenbosch.
She has additional training in ACLS (Advanced Cardiac Life Support) and PALS (Paediatric Advanced Life Support) as well as biostatistics and epidemiology.

Dr Van Deventer is currently working as a researcher at the Desmond Tutu Tuberculosis Centre at the University of Stellenbosch.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules